CASP3 and lung carcinoma: Benedetti et al. [30] attributed the anticancer effects of acyclovir against NCI-H1975 lung cancer cells to acyclovir’s role in mitochondrial DNA damage and activation of caspase-3, which triggers apoptosis in cancer cells.